Illumina will be at Nordic Precision Medicine Forum , Illumina will be present across the whole event and through the event app to contact our team. Discover how comphrensive genomic profiling can help to inform therapy decisions and see how Illumina can support your oncology workflow from sample-to-reporting .
Symposium: We’re pleased to announce that Illumina will be hosting our workshop at Nordic Precision Medicine Forum, “Liquid Biopsy Biomarkers for Cancer Research: Nation-wide Studies and Illumina Innovations ” on 28th April 16:00-17:00, Join us for an exciting overview of the applications of liquid biopsy-based biomarkers, insights into liquid biopsy testing and more! For more details please click here.
5’ Illumina: Innovations in Liquid Biopsy Research to Fight Cancer. Valentin Alcaniz & Annina Brofeldt - Illumina
20’ QuickDNA: Implementation of Liquid Biopsy into Lung Cancer Diagnostic Pathway. Dr Magdalena Meissner
20’ IMPRESS-NORWAY: Added Value of Liquid Biopsy Testing in Advanced Cancer. Dr Laxmi Silwal-Pandit
15’ Q&A - All Speakers
Dr. Laxmi Silwal-Pandit
Medical Special Advisor Unit for Study-Related Diagnostics, Dept. of Pathology, Oslo University Hospital (OUS)
Dr Magdalena Meissner MD, MRCP, MSc(Onc), PhD
Clinical Senior Lecturer in Medical Oncology - Cardiff University
Medical Oncology Consultant - Velindre University NHS Trust
Clinical Liquid Biopsy Lead - All Wales Medical Genomic Services
CReSt Co-theme Lead for Theme 1 (Precision and Mechanistic Oncology)